Thomas Templeman - 27 May 2021 Form 3 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Reporting relationship: Chief Technology Officer
Issuer ticker: CNTA
Reported as of: 27 May 2021
Net transaction value: $0
SEC form: 3
Accepted by SEC: 27 May 2021, 20:34:28 UTC
Next SEC filing: 04 Jun 2021
Source filing: View source filing
Reporting owner signature: /s/ Marella Thorell, attorney-in-fact

Key filing fact

Thomas Templeman filed Form 3 for Centessa Pharmaceuticals plc (CNTA) on 27 May 2021.

Key facts

This page summarizes Thomas Templeman's Form 3 filing for Centessa Pharmaceuticals plc (CNTA).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 27 May 2021, 20:34.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CNTA holding Derivative

Share Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 27 May 2021
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 500,338
Exercise price: $9.42
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

25% of the shares subject to such option shall vest and become exercisable on May 17, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.

Footnote F2

Represents A Ordinary Shares that will be redesignated as Ordinary Shares immediately prior to the closing of the initial public offering.

Footnote F3

Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

SEC remarks

Exhibit 24 - Power of Attorney